Stock Movers

Joining the discussion is Donita Sokova, a Bloomberg News cross-asset reporter specializing in M&A and market reactions. She dives into the drama around Netflix as Paramount extends its tender offer for Warner Bros. Discovery, impacting Netflix's stock. Carvana's shares surge following Barclays' price target increase, showcasing its remarkable comeback since 2022. Donita also touches on Meta's bounce back due to positive analyst sentiment and expectations surrounding AI hires, promising a promising outlook.

Danita Sokova, a cross-asset reporter at Bloomberg News, dives into the fluctuating stock market. She reveals why Netflix shares took a hit following news from Paramount Skydance about a critical vote against their deal with Warner Bros. On a more optimistic note, Carvana sees a surge as Barclays raises its price target significantly, forecasting a brighter future. P&G also shows promise with executives optimistic about improved US sales, hinting they'll meet guidance. Tune in for insightful market analysis!

Carmen Reinke, a Bloomberg reporter known for her market insights, shares intriguing developments in the stock market. Corcept Therapeutics impresses with a successful cancer trial, reducing death risk by 35%. Meanwhile, Abbott Labs struggles, forecasting disappointing earnings amidst missed sales expectations. On a high note, Arista Networks thrives with over 370% growth, fueled by AI spending and market upgrades. Carmen's analysis provides a captivating snapshot of today’s stock movers.

Intel shares soared 12% following a bullish outlook from Nvidia's CEO on the semiconductor industry. Meanwhile, Procter & Gamble reported stagnation in sales growth, citing cautious consumer spending, particularly in baby and family care products. The podcast also dives into Paramount's extended tender offer for Warner Bros. Discovery, highlighting the competitive media landscape. The hosts share insights on diaper demand trends and compare Netflix's financial strength to Paramount's, adding entertaining banter about the intricacies of deal-making.

Louise Moon, a Bloomberg breaking news editor known for her expertise in market analysis and corporate developments, dives into the financial landscape. She discusses Beazley’s significant rejection of Zurich’s takeover offer, deeming it undervalued. B&M’s struggles lead to a guidance cut as turnaround costs mount, but there's a glimmer of hope with signs of recovery. Telenor's strategic move to sell its stake in True Corp for $3.9 billion highlights a shift back to their Nordic roots. Tune in for insightful market trends!

Chloe Mene, a Bloomberg reporter specializing in company-specific reporting, shares insights on recent developments involving major European companies. She reveals how Volkswagen fortifies its cash position by delaying EV projects, which reassures investors. Meanwhile, B&M feels the sting of a profit warning after slashing guidance due to inventory issues, while Ubisoft faces turmoil with a 30% share drop following game project cancellations and studio closures. The conversation highlights the current struggles and future hopes of these industry giants.

Johnson & Johnson faces a 3.1% drop after reporting mixed drug sales and a court loss over baby powder, despite optimistic guidance for 2026. Meanwhile, Kraft Heinz declines as Berkshire Hathaway prepares to sell a significant portion of its shares. In a surprising twist, Nathan's Famous sees a surge in its stock price after being acquired by Smithfield Foods for $450 million, raising intriguing questions about brand continuity and its cultural significance.

Listen in as Moderna's shares soar after promising cancer therapy results. The buzz around Nathan's Famous grows with Smithfield Foods' acquisition for $450 million. Meanwhile, Kraft Heinz takes a dip as Berkshire Hathaway lists over 325 million shares for sale. The team also discusses the impact of rising programming costs on Netflix and the fluctuations in software stocks. Tune in for all the market highlights and insights!

Alexandra Seminova, a Bloomberg News equities reporter, dives into the latest market trends and corporate earnings. Netflix faces a rough road ahead with a disappointing earnings forecast as it ramps up programming. In contrast, Charles Schwab has seen a surge in trading volumes as investors capitalize on market momentum. United Airlines surprises by beating estimates and anticipates a booming 2026 thanks to high-spending travelers. Tune in for an engaging discussion on the dynamic forces shaping the market!

Netflix's shares dip as it forecasts lower Q1 earnings and pauses buybacks for a Warner Bros. acquisition. Meanwhile, Johnson & Johnson surpasses Q4 sales expectations, buoyed by new cancer treatments and ambitious 2026 projections, despite drug pricing deals. United Airlines also shines with an optimistic outlook fueled by high-demand travelers, echoing a cautious yet positive forecast for the aviation industry. The episode dives into these market movers and their potential impacts on investors.